Sarah Hudson Profile picture
Cardiologist- Heart Failure & Advanced Echo; Digital Health - Topol Digital Fellow 2019/2020; Data and process optimisation

Aug 30, 2021, 10 tweets

💥My top 10 learning points from the #ESCCongress 2021💥

A thread for cardiologists/general physicians

1) There is a treatment for HFpEF!

Empagliflozin significantly ⬇️composite of HF hospitalisation & CV death by 21%

Evidence: EMPEROR-Preserved nejm.org/doi/full/10.10…

1/n

2) A more aggressive BP target (110 to 130 Vs 130 to 150) in elderly patients resulted in lower rates of cardiovascular events

Evidence: STEP study -nejm.org/doi/full/10.10…

2/n #ESCCongress

3) Using a salt substitute ⬇️risk of stroke, major CV events and total mortality.

Evidence: SSaSS study - nejm.org/doi/full/10.10…

3/n #ESCCongress

4) Patients with OOHCA & ROSC without STE or LBBB on ECG have no benefit of immediate angiography Vs initial intensive care evaluation with delayed angiography if indicated

Evidence: TOMAHAWK - nejm.org/doi/full/10.10…

4/n #ESCCongress

5) Dapagliflozin decreases risk of serious ventricular arrhythmia, cardiac arrest or sudden death when added to conventional therapy in pts with HFrEF by 21%

Evidence: Post hoc analysis of DAPA HF - academic.oup.com/eurheartj/adva…

5/n #ESCCongress

6) Influenza vaccine given early after an MI or high-risk coronary disease results in a lower risk of all-cause death/MI/stent thrombosis

Evidence: IAMI - ahajournals.org/doi/10.1161/CI…

6/n #ESCCongress

7)Giving high risk COVID pts treatment dose LMWH has a NNT of 8 to prevent one major thromboembolic event and death

Evidence: HEP-COVID trial (not yet published; clinicaltrials.gov/ct2/show/NCT04…)

7/n #ESCCongress

8) Putting an ILR into pts will find more AF (threefold increase in detection) but even with anticoagulation current evidence does NOT show this to decrease stroke (?due to short duration of AF)

Evidence: LOOP study - thelancet.com/journals/lance…

8/n #ESCCongress

9) In pts discharged after at least 3d hospitalisation with COVID,use of rivaroxaban 10mg OD for 35d in those with ⬆️IMPROVE score resulted in better clinical outcomes without increased bleeding

Evidence:MICHELLE trial,not yet published acc.org/latest-in-card…

9/n #ESCCongress

10) Exercise improves freedom from AF and decreases AF symptom severity

Evidence: ACTIVE AF (not yet published; escardio.org/The-ESC/Press-…)

10/10 #ESCCongress

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling